Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OMNICELL, INC.OMCL · Entity 4666 | Director · CHAIRMAN, CEO | August 15, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OMNICELL, INC.
Report date August 15, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 511,095.7173 |
Reported balance
After 2026-08-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-15 · Tax withholding · Disposed 12,350 · Balance 511,095.7173 F1: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. F2: The balance is adjusted to reflect 261.6432 shares purchased under the Issuer's Employee Stock Purchase Plan on 8/15/26. |
| Common StockSEC Table I · non-derivative | IndirectIn Trust with Wife | 345,861 |
Reported balance
Holding disclosure · report date 2026-08-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 345,861 F3: Shares held in trust with Mr. Lipps' wife. |
| Common StockSEC Table I · non-derivative | IndirectIn Trust for Children | 8,051 |
Reported balance
Holding disclosure · report date 2026-08-15 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 8,051 F4: Shares held in trust for the benefit of Mr. Lipps' children. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.
F2: The balance is adjusted to reflect 261.6432 shares purchased under the Issuer's Employee Stock Purchase Plan on 8/15/26.
F3: Shares held in trust with Mr. Lipps' wife.
F4: Shares held in trust for the benefit of Mr. Lipps' children.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Invuity, Inc.
Report date October 23, 2018 · Filed October 23, 2018
Section 16 reporting ended · disclosed 2018-10-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2018-10-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-10-23 · Disposition to issuer · Disposed 63,452 · Balance 52,231 F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price"). Row 2 · 2018-10-23 · Disposition to issuer · Disposed 52,231 · Balance 0 F2: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock. F3: The RSUs were cancelled pursuant to the Merger Agreement in exchange for an amount in cash per underlying share equal to the Offer Price. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2018-10-23 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2018-10-23 · Disposition to issuer · Disposed 7,722 · Balance 0 F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price"). F4: The shares are held by Lipps Family Ventures, of which the Reporting Person is a Manager. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.15 · Expires 2024-07-26 | Direct | 0 |
Reported balance
After 2018-10-23 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-10-23 · Disposition to issuer · Disposed 2,054 · Balance 0 F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.87 · Expires 2021-05-19 | Direct | 0 |
Reported balance
After 2018-10-23 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-10-23 · Disposition to issuer · Disposed 28,900 · Balance 0 F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price").
F2: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock.
F3: The RSUs were cancelled pursuant to the Merger Agreement in exchange for an amount in cash per underlying share equal to the Offer Price.
F4: The shares are held by Lipps Family Ventures, of which the Reporting Person is a Manager.
F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 09, 2020 Filed Dec 9, 2020 22:23 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 9,586 | $124.12 | $1,189,788.44 |
DisclosureSEC source: 0001179110-20-011797 · edgar.xml · nonDerivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,216 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. F5 · price: The price reported in Column 4 is the average price of $124.1173. The sold price range between $123.75 to $124.70. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 09, 2020 Filed Dec 9, 2020 22:23 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,225 | $121.22 | $148,492.30 |
DisclosureSEC source: 0001179110-20-011797 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,802 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. F6 · price: The price reported in Column 4 is the average price of $121.2182. The sold price range between $121.00 to $121.41. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 09, 2020 Filed Dec 9, 2020 22:23 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 14,089 | $120.34 | $1,695,485.76 |
DisclosureSEC source: 0001179110-20-011797 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,027 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. F4 · price: The price reported in Column 4 is the average price of $120.3411. The sold price range between $120.00 to $120.95. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 09, 2020 Filed Dec 9, 2020 22:23 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-011797 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. Read SEC document |
| December 08, 2020 Filed Dec 8, 2020 21:53 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-20-011775 · edgar.xml · derivative · entry 8 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,500 shares Expires 2025-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. Read SEC document |
| December 08, 2020 Filed Dec 8, 2020 21:53 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 651 | $111.07 | $72,307.48 |
DisclosureSEC source: 0001179110-20-011775 · edgar.xml · nonDerivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,116 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. F5 · price: The price reported in Column 4 is the average price of $111.0714. The sold price range between $111.01 to $111.11. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 08, 2020 Filed Dec 8, 2020 21:53 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 651 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-011775 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. Read SEC document |
| December 08, 2020 Filed Dec 8, 2020 21:53 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 16,849 | $110.54 | $1,862,410.95 |
DisclosureSEC source: 0001179110-20-011775 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,116 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. F4 · price: The price reported in Column 4 is the average price of $110.5354. The sold price range between $110.00 to $110.99. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 08, 2020 Filed Dec 8, 2020 21:53 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 16,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-011775 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. Read SEC document |
| November 23, 2020 Filed Nov 23, 2020 23:24 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 12,600 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-20-011291 · edgar.xml · derivative · entry 9 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,600 shares Expires 2025-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. Read SEC document |
| November 23, 2020 Filed Nov 23, 2020 23:24 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 12,600 | $105.40 | $1,328,029.92 |
DisclosureSEC source: 0001179110-20-011291 · edgar.xml · nonDerivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,116 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. F5 · price: The price reported in Column 4 is the average price of $105.3992. The sold price range between $105.0050 to $105.9200. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 23, 2020 Filed Nov 23, 2020 23:24 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 12,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-011291 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. Read SEC document |
| November 20, 2020 Filed Nov 23, 2020 23:24 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 2,400 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-20-011291 · edgar.xml · derivative · entry 8 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,400 shares Expires 2025-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. Read SEC document |
| November 20, 2020 Filed Nov 23, 2020 23:24 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 2,400 | $105.01 | $252,034.08 |
DisclosureSEC source: 0001179110-20-011291 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,116 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. F4 · price: The price reported in Column 4 is the average price of $105.0142. The sold price range between $105.00 to $105.03. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 20, 2020 Filed Nov 23, 2020 23:24 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 2,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-011291 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. Read SEC document |
| November 04, 2020 Filed Nov 4, 2020 22:48 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,206 | $90.57 | $109,229.23 |
DisclosureSEC source: 0001179110-20-010828 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 229,113 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. F6 · price: The price reported in Column 4 is the average price of $90.5715. The sold price range between $90.46 to $90.68. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| November 04, 2020 Filed Nov 4, 2020 22:48 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 5,172 | $90.01 | $465,528.62 |
DisclosureSEC source: 0001179110-20-010828 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 230,319 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. F5 · price: The price reported in Column 4 is the average price of $90.0094. The sold price range between $89.45 to $90.42. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| November 04, 2020 Filed Nov 4, 2020 22:48 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 5,057 | $88.92 | $449,681.59 |
DisclosureSEC source: 0001179110-20-010828 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 235,491 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. F4 · price: The price reported in Column 4 is the average price of $88.9226. The sold price range between $88.45 to $89.44. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| September 16, 2020 Filed Sep 16, 2020 23:56 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 300 | $76.15 | $22,843.50 |
DisclosureSEC source: 0001179110-20-009837 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 240,548 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. F6 · price: The price reported in Column 4 is the average price of $76.1450. The sold price range between $76.06 to $76.19. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| September 16, 2020 Filed Sep 16, 2020 23:56 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 13,443 | $75.63 | $1,016,657.79 |
DisclosureSEC source: 0001179110-20-009837 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 240,848 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. F5 · price: The price reported in Column 4 is the average price of $75.6273. The sold price range between $75.03 to $76.02. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 23:56 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,400 | $75.01 | $105,008.96 |
DisclosureSEC source: 0001179110-20-009837 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 254,291 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan adopted by the reporting person on February 20, 2020. F4 · price: The price reported in Column 4 is the average price of $75.0064. The sold price range between $75.00 to $75.03. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| July 29, 2020 Filed Jul 30, 2020 16:42 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 3,718 | $75.15 | $279,398.41 |
DisclosureSEC source: 0001179110-20-008559 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,398 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F4 · price: The price reported in Column 4 is the average price of $75.1475. The sold price range between $75.00 to $75.57. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 29, 2020 Filed Sep 2, 2020 23:34 UTC Amendment | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 3,718 | $75.15 | $279,398.41 |
DisclosureSEC source: 0001179110-20-009495 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 255,691 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F5 · shares: 3718 shares were sold from shares held in trust with Mr. Lipps' wife. This is to just adjust the balance between directly held and indirectly held balances. F4 · price: The price reported in Column 4 is the average price of $75.1475. The sold price range between $75.00 to $75.57. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · balance_after: 3718 shares were sold from shares held in trust with Mr. Lipps' wife. This is to just adjust the balance between directly held and indirectly held balances. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 19:30 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 10,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-007413 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,116 F4 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| May 14, 2020 Filed May 14, 2020 22:42 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionEmployee Stock Option NQ (right to buy) · Derivative | 5,500 | $0.00 Strike: $44.25 | $0.00 |
DisclosureSEC source: 0001179110-20-006042 · edgar.xml · derivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,500 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2020 Filed May 14, 2020 22:42 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 5,500 | $60.39 | $332,145.00 |
DisclosureSEC source: 0001179110-20-006042 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: NQ Cash Exercise, no sales. Read SEC document |
| May 13, 2020 Filed May 14, 2020 22:42 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionEmployee Stock Option NQ (right to buy) · Derivative | 2,450 | $0.00 Strike: $44.25 | $0.00 |
DisclosureSEC source: 0001179110-20-006042 · edgar.xml · derivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,450 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2020 Filed May 14, 2020 22:42 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 2,450 | $59.36 | $145,432.00 |
DisclosureSEC source: 0001179110-20-006042 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,852 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: NQ Cash Exercise, no sales. Read SEC document |
| April 03, 2020 Filed Apr 3, 2020 20:58 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 896 | $68.00 | $60,925.04 |
DisclosureSEC source: 0001179110-20-004647 · edgar.xml · nonDerivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · I Trust with Wife Disclosed balance after: 259,409 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F7 · price: The price reported in Column 4 is the average price of $67.9967. The sold price range between $67.54 to $68.39. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| April 03, 2020 Filed Apr 3, 2020 20:58 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 800 | $66.95 | $53,560.96 |
DisclosureSEC source: 0001179110-20-004647 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 260,305 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F6 · price: The price reported in Column 4 is the average price of $66.9512. The sold price range between $66.51 to $67.24. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| April 03, 2020 Filed Apr 3, 2020 20:58 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 2,155 | $65.83 | $141,859.56 |
DisclosureSEC source: 0001179110-20-004647 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 261,105 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F5 · price: The price reported in Column 4 is the average price of $65.8281. The sold price range between $65.35 to $66.25. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| April 03, 2020 Filed Apr 3, 2020 20:58 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,149 | $64.60 | $74,220.92 |
DisclosureSEC source: 0001179110-20-004647 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 263,260 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F4 · price: The price reported in Column 4 is the average price of $64.5961. The sold price range between $64.34 to $64.84. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 16:13 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,950 | $63.63 | $124,077.53 |
DisclosureSEC source: 0001179110-20-004588 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 264,409 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F6 · price: The price reported in Column 4 is the average price of $63.6295. The sold price range between $63.36 to $64.34. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 16:13 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 2,700 | $62.72 | $169,331.04 |
DisclosureSEC source: 0001179110-20-004588 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 266,359 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F5 · price: The price reported in Column 4 is the average price of $62.7152. The sold price range between $62.13 to $63.1250. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 16:13 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 350 | $60.63 | $21,222.01 |
DisclosureSEC source: 0001179110-20-004588 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 269,059 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F4 · price: The price reported in Column 4 is the average price of $60.6343. The sold price range between $60.28 to $60.76. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 19:15 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 4,864 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003032 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,402 F3 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 19:39 UTC | OMNICELL, INC. OMCL · Entity 4666 | GiftCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-001739 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 269,409 F3 · shares: Gifted shares from founders 15,000 shares to Donor Advised Fund. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 19:39 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantStock Options NQ (Right to Buy) · Derivative | 89,874 | $0.00 Strike: $90.19 | $0.00 |
DisclosureSEC source: 0001179110-20-001739 · edgar.xml · derivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,874 Underlying: Common Stock · 89,874 shares Expires 2030-02-12 F5 · shares: NQ: Shares shall vest ratably over 48 month period, with a year cliff. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 19:39 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 42,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-001739 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,266 F4 · shares: The Performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2021 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2021 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% of the numbers reflected above, depending upon the Company's performance. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 21:28 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStpck Options NQ (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-20-000416 · edgar.xml · derivative · entry 9 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 21:28 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 2,568 | $82.11 | $210,850.01 |
DisclosureSEC source: 0001179110-20-000416 · edgar.xml · nonDerivative · entry 8 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,466 F7 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F5 · price: The price reported in Column 4 is the average price of $82.1067. The sold price range between $81.84 to $82.71. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 21:28 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 21,432 | $81.33 | $1,743,002.41 |
DisclosureSEC source: 0001179110-20-000416 · edgar.xml · nonDerivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,034 F7 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F6 · price: The price reported in Column 4 is the average price of $81.3271. The sold price range between $80.83 to $81.83. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 21:28 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-000416 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,466 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 21:28 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 400 | $82.11 | $32,845.00 |
DisclosureSEC source: 0001179110-20-000416 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 284,409 F7 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F4 · price: The price reported in Column 4 is the average price of $82.1125. The sold price range between $82.03 to $82.22. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 21:28 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 4,600 | $81.37 | $374,297.86 |
DisclosureSEC source: 0001179110-20-000416 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 284,809 F7 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F3 · price: The price reported in Column 4 is the average price of $81.3691. The sold price range between $80.98 to $81.86. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| December 15, 2019 Filed Dec 16, 2019 20:05 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 12,021 | $79.69 | $957,953.49 |
DisclosureSEC source: 0001179110-19-012781 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,466 F3 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 16:23 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 20,902 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-19-011995 · edgar.xml · derivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,902 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 16:23 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 5,280 | $79.25 | $418,430.50 |
DisclosureSEC source: 0001179110-19-011995 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,409 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan F5 · price: The price reported in Column 4 is the average price of $79.2482. The sold price range between $79.0250 to $79.39. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 16:23 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 15,622 | $78.58 | $1,227,587.70 |
DisclosureSEC source: 0001179110-19-011995 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,689 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan F4 · price: The price reported in Column 4 is the average price of $78.5807. The sold price range between $78.00 to $78.99. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 16:23 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 20,902 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-011995 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.